[DIA Europe 2023] DRA – A Key Initiative to Future Proof EU Regulatory Ecosystem

Logo
Presented by

Esteban Herrero-Martinez, AbbVie; Nasir Hussain, Gilead; Tony Humphreys, EMA; Hugo Hamel, Health Canada.

About this talk

Watch this exciting discussion on the field of Dynamic Regulatory Assessment (DRA) and witness this significant multi-stakeholder engagement in a pivotal year 2023 with new legislation under the Pharmaceutical Strategy.
Related topics:

More from this channel

Upcoming talks (0)
On-demand talks (53)
Subscribers (530)
The Drug Information Association (DIA) is a global and neutral association that mobilizes the life science community (regulators, industry, healthcare professionals, patients, payers, and students) to identify and tackle the most complex health challenges. DIA brings all these stakeholders together to find and discuss solutions, build a more robust and innovative healthcare ecosystem and, ultimately, improve patient outcomes worldwide. DIA executes its mission by fostering timely and critical conversations and networking sessions across many platforms, including conferences, workshops, DIA-led research projects, structured training, eLearning courses, digital content platforms, and publications, without corporate funding.